positions available now

Tag Archives: Quality Use of Medicines

Pricing is important, but what about access and quality use of medicines?

The recent PBS Access and Sustainability package provides significant savings from pricing measures including removing the originator brand from price disclosure calculations, a one-off 5% reduction to F1 medicines listed for at least 5 years, flow on reductions for F2 … Continue reading

Posted in Life Sciences Industry, Market Access | Tagged , , | Comments Off on Pricing is important, but what about access and quality use of medicines?

It’s Quality Time

Quality Use of Medicines (QUM) is one of Australia’s National Medicines Policy’s central objectives. But what does it mean in practice? Beyond the ‘right drug, right dose, right time’ adage, QUM can have different meanings for different people and organisations: … Continue reading

Posted in Clinical Development, Life Sciences Industry, Market Access, Medical Services, Regulatory Services | Tagged | Comments Off on It’s Quality Time

Right Message, Right People, Right Time

The pharmaceutical industry needs to expand the ‘right drug, right dose, right time’ mantra. Continue reading

Posted in Life Sciences Industry | Tagged , | Comments Off on Right Message, Right People, Right Time
Copyright © 2014 Commercial Eyes